|
Q3 2026
|
77 |
6,465,822
|
RVMD, BROOKDALE SR LIVING INC, CNC, UTHR
|
13F-HR
|
11/16/2026 |
000121390026120609 |
|
Q2 2026
|
82 |
9,586,028
|
NUVL, BROOKDALE SR LIVING INC, RVMD, PRAX
|
13F-HR
|
8/14/2026 |
000121390026089991 |
|
Q1 2026
|
82 |
8,476,380
|
NUVL, BROOKDALE SR LIVING INC, COGT, PRAX
|
13F-HR
|
5/15/2026 |
000121390026057678 |
|
Q4 2025
|
150 |
7,800,676
|
NUVL, BROOKDALE SR LIVING INC, COGT, PRAX
|
13F-HR
|
2/17/2026 |
000121390026017265 |
|
Q3 2025
|
152 |
6,524,910
|
NUVL, CNC, MRUS, VTRS
|
13F-HR
|
11/14/2025 |
000121390025110851 |
|
Q2 2025
|
124 |
5,509,809
|
NUVL, OSCR, VTRS, MRUS
|
13F-HR
|
8/14/2025 |
000121390025076586 |
|
Q1 2025
|
123 |
5,044,377
|
NUVL, VTRS, INTEGRA LIFESCIENCES HLDGS C, NBIX
|
13F-HR
|
5/15/2025 |
000121390025044138 |
|
Q4 2024
|
106 |
5,256,971
|
NUVL, VTRS, INTEGRA LIFESCIENCES HLDGS C, CNC
|
13F-HR
|
2/14/2025 |
000121390025014236 |
|
Q3 2024
|
443 |
6,692,806
|
NUVL, VTRS, CNC, MRUS
|
13F-HR
|
11/14/2024 |
000121390024098387 |
|
Q2 2024
|
433 |
6,010,511
|
NUVL, INSMED INC, VTRS, CNC
|
13F-HR
|
8/14/2024 |
000095015924000249 |
|
Q1 2024
|
367 |
5,748,070
|
NUVL, VTRS, CNC, LRMR
|
13F-HR
|
5/15/2024 |
000095015924000176 |
|
Q4 2023
|
222 |
5,415,639
|
NUVL, GLAUKOS CORP, VTRS, INVITAE CORP
|
13F-HR
|
2/14/2024 |
000095015924000096 |
|
Q3 2023
|
88 |
4,538,793
|
NUVL, GLAUKOS CORP, VTRS, INVITAE CORP
|
13F-HR
|
11/14/2023 |
000095015923000305 |
|
Q2 2023
|
101 |
4,684,196
|
NUVL, GLAUKOS CORP, VTRS, AMED
|
13F-HR
|
8/14/2023 |
000095015923000249 |
|
Q1 2023
|
106 |
4,485,670
|
NUVL, GLAUKOS CORP, NBIX, CPRX
|
13F-HR
|
5/15/2023 |
000095015923000173 |
|
Q4 2022
|
104 |
4,831,008
|
NUVL, GLAUKOS CORP, INVITAE CORP, NBIX
|
13F-HR
|
2/14/2023 |
000095015923000074 |
|
Q3 2022
|
131 |
5,005,800
|
NUVL, GLAUKOS CORP, AERIE PHARMACEUTICALS INC, INVITAE CORP
|
13F-HR
|
11/14/2022 |
000095015922000241 |
|
Q2 2022
|
127 |
4,746,411
|
GLAUKOS CORP, NUVL, VTRS, AHCO
|
13F-HR
|
8/15/2022 |
000095015922000199 |
|
Q1 2022
|
122 |
4,470,333
|
GLAUKOS CORP, NUVL, VTRS, AHCO
|
13F-HR
|
5/16/2022 |
000095015922000122 |
|
Q4 2021
|
127 |
4,748,892
|
NUVL, VTRS, AHCO, GLAUKOS CORP
|
13F-HR
|
2/14/2022 |
000095015922000077 |
|
Q3 2021
|
133 |
5,114,509
|
NUVL, VTRS, INVITAE CORP, AHCO
|
13F-HR
|
11/15/2021 |
000095015921000326 |
|
Q2 2021
|
143 |
5,629,668
|
VTRS, OMIC, INVITAE CORP, CMAX
|
13F-HR
|
8/16/2021 |
000095015921000256 |
|
Q1 2021
|
133 |
4,758,345
|
INVITAE CORP, VTRS, NEVRO CORP, AERIE PHARMACEUTICALS INC
|
13F-HR
|
5/17/2021 |
000095015921000154 |
|
Q4 2020
|
129 |
5,059,782
|
VTRS, INVITAE CORP, NEVRO CORP, NUVASIVE INC
|
13F-HR
|
2/16/2021 |
000095015921000090 |
|
Q3 2020
|
105 |
4,106,901
|
INVITAE CORP, MYL, IMMU, NEVRO CORP
|
RESTATEMENT
|
12/30/2020 |
000095015920000284 |
|
Q2 2020
|
93 |
3,433,887
|
HORIZON PHARMA INVT LTD, MYL, NEVRO CORP, SDGR
|
13F-HR
|
8/14/2020 |
000095015920000206 |
|
Q1 2020
|
90 |
3,151,113
|
AHCO, MYL, HZNP, HORIZON PHARMA INVT LTD
|
13F-HR
|
5/15/2020 |
000095015920000137 |
|
Q4 2019
|
76 |
3,131,706
|
HORIZON PHARMA INVT LTD, AHCO, HZNP, MYL
|
13F-HR
|
2/14/2020 |
000095015920000051 |
|
Q3 2019
|
95 |
2,447,802
|
HZNP, HORIZON PHARMA INVT LTD, MYL, NEVRO CORP
|
13F-HR
|
11/14/2019 |
000095015919000232 |
|
Q2 2019
|
97 |
2,780,311
|
HZNP, HORIZON PHARMA INVT LTD, MYL, ORTX
|
13F-HR
|
8/14/2019 |
000156761919016972 |
|
Q1 2019
|
93 |
2,607,815
|
HZNP, FIXX, ORTX, HORIZON PHARMA INVT LTD
|
13F-HR
|
5/15/2019 |
000156761919011266 |
|
Q4 2018
|
99 |
2,461,050
|
HZNP, ORTX, FIXX, HORIZON PHARMA INVT LTD
|
13F-HR
|
2/14/2019 |
000156761919004367 |
|
Q3 2018
|
103 |
2,747,044
|
HZNP, FIXX, HORIZON PHARMA INVT LTD, NEVRO CORP
|
13F-HR
|
11/14/2018 |
000156761918006280 |
|
Q2 2018
|
114 |
2,811,148
|
MNKKQ, HZNP, FIXX, HORIZON PHARMA INVT LTD
|
13F-HR
|
8/14/2018 |
000156761918001075 |
|
Q1 2018
|
118 |
2,818,382
|
MNKKQ, MYL, FIXX, HZNP
|
13F-HR
|
5/15/2018 |
000114036118023958 |
|
Q4 2017
|
98 |
2,534,140
|
MNKKQ, MYL, HZNP, DXCM
|
13F-HR
|
2/14/2018 |
000114036118008191 |
|
Q3 2017
|
91 |
2,213,322
|
AVXS, MCK, MYL, HZNP
|
13F-HR
|
11/13/2017 |
000114036117042010 |
|
Q2 2017
|
85 |
1,809,812
|
AVXS, HZNP, NXTM, GILD
|
13F-HR
|
8/14/2017 |
000114036117031950 |
|
Q1 2017
|
106 |
2,575,295
|
AVXS, HZNP, NXTM, ENDOLOGIX INC
|
13F-HR
|
5/15/2017 |
000114036117020638 |
|
Q4 2016
|
102 |
2,413,120
|
HZNP, NXTM, AVXS, PTLA
|
13F-HR
|
2/14/2017 |
000114036117007402 |
|
Q3 2016
|
90 |
2,150,130
|
GWPH, PTLA, HZNP, NXTM
|
13F-HR
|
11/14/2016 |
000114036116086449 |
|
Q2 2016
|
106 |
2,544,485
|
HZNP, NXTM, GWPH, PTLA
|
13F-HR
|
8/15/2016 |
000114036116076356 |
|
Q1 2016
|
105 |
2,348,708
|
HZNP, MYL, NXTM, HEALTHWAYS INC
|
13F-HR
|
5/16/2016 |
000114036116065661 |
|
Q4 2015
|
109 |
2,377,446
|
HZNP, NXTM, DYAX, ADPTQ
|
13F-HR
|
2/16/2016 |
000114036116053179 |
|
Q3 2015
|
134 |
2,554,080
|
HZNP, ALLSCRIPTS HEALTHCARE SOLUTN, NXTM, GSK
|
13F-HR
|
11/16/2015 |
000114036115041667 |
|
Q2 2015
|
120 |
2,986,705
|
HZNP, ALLSCRIPTS HEALTHCARE SOLUTN, FLML, NXTM
|
13F-HR
|
8/14/2015 |
000114036115032279 |
|
Q1 2015
|
1 |
1,044
|
CORSICANTO LTD
|
NEW HOLDINGS
|
8/14/2015 |
000114036115032272 |
|
Q1 2015
|
123 |
3,054,535
|
ASPX, HZNP, ALLSCRIPTS HEALTHCARE SOLUTN, ABBV
|
13F-HR
|
5/15/2015 |
000114036115020245 |
|
Q4 2014
|
111 |
2,678,116
|
AUXL, ASPX, HZNP, AGN
|
13F-HR
|
2/17/2015 |
000114036115007446 |
|
Q3 2014
|
131 |
2,463,825
|
AUXL, DENDREON CORP, AGN, NXTM
|
13F-HR
|
11/14/2014 |
000114036114042282 |
|
Q2 2014
|
127 |
2,245,815
|
DENDREON CORP, AUXL, ITMN, FLML
|
13F-HR
|
8/14/2014 |
000114036114032861 |
|
Q1 2014
|
124 |
2,178,289
|
DENDREON CORP, HUM calls, INTERMUNE INC, FLML
|
13F-HR
|
5/15/2014 |
000114036114021676 |
|
Q4 2013
|
106 |
1,773,581
|
DENDREON CORP, AUXL, QCOR, CBST calls
|
13F-HR
|
2/14/2014 |
000114036114007925 |